DK1987817T3 - Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputation - Google Patents
Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputationInfo
- Publication number
- DK1987817T3 DK1987817T3 DK07702319T DK07702319T DK1987817T3 DK 1987817 T3 DK1987817 T3 DK 1987817T3 DK 07702319 T DK07702319 T DK 07702319T DK 07702319 T DK07702319 T DK 07702319T DK 1987817 T3 DK1987817 T3 DK 1987817T3
- Authority
- DK
- Denmark
- Prior art keywords
- microspheres
- prevention
- pharmaceutical composition
- diabetic foot
- foot amputation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060021A CU23388B6 (es) | 2006-01-31 | 2006-01-31 | Composición farmacéutica de microesferas para prevenir la amputación del pie diabético |
PCT/CU2007/000002 WO2007087759A2 (es) | 2006-01-31 | 2007-01-29 | Composición farmacéutica de microesferas para prevenir la amputación del pie diabético |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1987817T3 true DK1987817T3 (da) | 2009-11-30 |
Family
ID=38185604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07702319T DK1987817T3 (da) | 2006-01-31 | 2007-01-29 | Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputation |
Country Status (24)
Country | Link |
---|---|
US (1) | US8741848B2 (es) |
EP (1) | EP1987817B1 (es) |
JP (1) | JP5219841B2 (es) |
KR (1) | KR101401273B1 (es) |
CN (2) | CN103933552A (es) |
AR (1) | AR059234A1 (es) |
AT (1) | ATE437631T1 (es) |
AU (1) | AU2007211753B2 (es) |
BR (1) | BRPI0707395A2 (es) |
CA (1) | CA2640743C (es) |
CU (1) | CU23388B6 (es) |
CY (1) | CY1109513T1 (es) |
DE (1) | DE602007001786D1 (es) |
DK (1) | DK1987817T3 (es) |
ES (1) | ES2330688T3 (es) |
HK (1) | HK1198743A1 (es) |
MY (1) | MY143742A (es) |
PL (1) | PL1987817T3 (es) |
PT (1) | PT1987817E (es) |
RU (1) | RU2426528C2 (es) |
SG (1) | SG169366A1 (es) |
SI (1) | SI1987817T1 (es) |
WO (1) | WO2007087759A2 (es) |
ZA (1) | ZA200806648B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CU23411B6 (es) * | 2005-12-29 | 2009-09-08 | Ct Ingenieria Genetica Biotech | Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético |
ES2340902B1 (es) | 2008-07-01 | 2011-05-03 | Laboratorios Farmaceuticos Rovi, S.A. | Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas. |
GB0814302D0 (en) | 2008-08-05 | 2008-10-01 | Coretherapix Slu | Compounds and methods |
KR101156094B1 (ko) * | 2010-02-22 | 2012-06-20 | 경상대학교산학협력단 | 약물송달을 위한 양친성 PHA-mPEG 공중합 나노 컨테이너 |
ES2357601B1 (es) | 2011-01-26 | 2012-03-21 | Laboratorios Farmacéuticos Rovi, S.A. | Procedimiento de preparación de derivados de glicosaminoglicanos donadores de óxido n�?trico y su uso en tratamiento de úlceras crónicas. |
EP2737895A1 (en) * | 2012-11-30 | 2014-06-04 | Praxis Pharmaceutical, S.A. | Microparticles with EGF, method of preparation and use |
EP2821077A1 (en) | 2013-07-04 | 2015-01-07 | Praxis Biopharma Research Institute | Lipid nanoparticles for wound healing |
EP3097922A1 (fr) | 2015-05-28 | 2016-11-30 | Denis Barritault | Composition pour le traitement des lesions tissulaires |
CN106267163A (zh) * | 2015-06-09 | 2017-01-04 | 济南博创医药科技有限公司 | 一种治疗皮肤创伤的药物组合物及其药物制剂 |
MX2016016339A (es) * | 2016-12-09 | 2018-06-08 | Desarrolladora Y Com De Tecnologias Biomedicas Decotecbio S A S De C V | Composicion coadyuvante de un factor de crecimiento y un neuropeptido para acelerar la cicatrizacion de heridas y la repitelizacion de organos. |
KR102218427B1 (ko) * | 2017-09-20 | 2021-02-22 | 차의과학대학교 산학협력단 | 단백질 약물을 포함하는 코아세르베이트 조성물 및 이를 포함하는 창상 치료제 |
CU20190022A7 (es) * | 2019-03-18 | 2020-10-20 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición farmacéutica para el tratamiento de la úlcera del pie diabético |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
JPS60100516A (ja) | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
NZ226171A (en) | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
JP2670680B2 (ja) * | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
US5034375A (en) | 1988-08-10 | 1991-07-23 | Institute Of Molecular Biology, Inc. | Process of wound healing using PDGF and EGF |
US4944948A (en) | 1989-02-24 | 1990-07-31 | Liposome Technology, Inc. | EGF/Liposome gel composition and method |
IL93996A0 (en) | 1989-04-04 | 1991-01-31 | Alcon Lab Inc | Pharmaceutical composition containing a liposome |
US5130298A (en) | 1989-05-16 | 1992-07-14 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
WO1991001719A1 (en) | 1989-08-01 | 1991-02-21 | The University Of Michigan | Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes |
AU629316B2 (en) | 1990-04-11 | 1992-10-01 | Flora Inc. | Periodontal disease treatment system |
US6902743B1 (en) * | 1995-05-22 | 2005-06-07 | The United States Of America As Represented By The Secretary Of The Army | Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix |
JP2000511512A (ja) * | 1996-05-03 | 2000-09-05 | イノジェネティックス・ナムローゼ・フェンノートシャップ | 酸化ポリサッカライドで架橋したゼラチンを含有する新規医薬 |
US5861149A (en) | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
US6706289B2 (en) * | 2000-10-31 | 2004-03-16 | Pr Pharmaceuticals, Inc. | Methods and compositions for enhanced delivery of bioactive molecules |
HK1077740A1 (en) * | 2001-12-20 | 2006-02-24 | Ct Ingenieria Genetica Biotech | Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation |
US7517528B2 (en) | 2002-03-12 | 2009-04-14 | Bio-Click Technologies, Ltd. | Method and composition for treating skin wounds with epidermal growth factor |
CN1720989A (zh) | 2004-07-15 | 2006-01-18 | 深圳市清华源兴生物医药科技有限公司 | 一种表皮生长因子缓释微球及其制备方法与应用 |
CU23411B6 (es) | 2005-12-29 | 2009-09-08 | Ct Ingenieria Genetica Biotech | Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético |
-
2006
- 2006-01-31 CU CU20060021A patent/CU23388B6/es unknown
-
2007
- 2007-01-29 SG SG201100715-0A patent/SG169366A1/en unknown
- 2007-01-29 AT AT07702319T patent/ATE437631T1/de active
- 2007-01-29 DK DK07702319T patent/DK1987817T3/da active
- 2007-01-29 EP EP07702319A patent/EP1987817B1/en active Active
- 2007-01-29 AU AU2007211753A patent/AU2007211753B2/en active Active
- 2007-01-29 DE DE602007001786T patent/DE602007001786D1/de active Active
- 2007-01-29 MY MYPI20082850A patent/MY143742A/en unknown
- 2007-01-29 CN CN201410189221.8A patent/CN103933552A/zh active Pending
- 2007-01-29 ES ES07702319T patent/ES2330688T3/es active Active
- 2007-01-29 BR BRPI0707395-0A patent/BRPI0707395A2/pt not_active Application Discontinuation
- 2007-01-29 PL PL07702319T patent/PL1987817T3/pl unknown
- 2007-01-29 PT PT07702319T patent/PT1987817E/pt unknown
- 2007-01-29 US US12/162,505 patent/US8741848B2/en active Active
- 2007-01-29 CA CA2640743A patent/CA2640743C/en active Active
- 2007-01-29 JP JP2008552668A patent/JP5219841B2/ja active Active
- 2007-01-29 WO PCT/CU2007/000002 patent/WO2007087759A2/es active Search and Examination
- 2007-01-29 SI SI200730087T patent/SI1987817T1/sl unknown
- 2007-01-29 CN CNA2007800090345A patent/CN101400338A/zh active Pending
- 2007-01-29 KR KR1020087021210A patent/KR101401273B1/ko active IP Right Grant
- 2007-01-29 RU RU2008135354/15A patent/RU2426528C2/ru active
- 2007-01-30 AR ARP070100377A patent/AR059234A1/es unknown
-
2008
- 2008-07-30 ZA ZA200806648A patent/ZA200806648B/xx unknown
-
2009
- 2009-10-23 CY CY20091101105T patent/CY1109513T1/el unknown
-
2014
- 2014-12-04 HK HK14112245.2A patent/HK1198743A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
SG169366A1 (en) | 2011-03-30 |
KR20080096804A (ko) | 2008-11-03 |
CN103933552A (zh) | 2014-07-23 |
HK1198743A1 (en) | 2015-06-05 |
JP2009525288A (ja) | 2009-07-09 |
RU2008135354A (ru) | 2010-03-10 |
ES2330688T3 (es) | 2009-12-14 |
ZA200806648B (en) | 2009-05-27 |
US8741848B2 (en) | 2014-06-03 |
CN101400338A (zh) | 2009-04-01 |
CA2640743C (en) | 2012-05-15 |
WO2007087759A2 (es) | 2007-08-09 |
SI1987817T1 (sl) | 2009-12-31 |
AU2007211753A1 (en) | 2007-08-09 |
AU2007211753B2 (en) | 2012-03-01 |
CY1109513T1 (el) | 2014-08-13 |
MY143742A (en) | 2011-07-15 |
DE602007001786D1 (de) | 2009-09-10 |
ATE437631T1 (de) | 2009-08-15 |
JP5219841B2 (ja) | 2013-06-26 |
PT1987817E (pt) | 2009-10-26 |
EP1987817B1 (en) | 2009-07-29 |
CU23388B6 (es) | 2009-07-16 |
AR059234A1 (es) | 2008-03-19 |
RU2426528C2 (ru) | 2011-08-20 |
CA2640743A1 (en) | 2007-08-09 |
WO2007087759A3 (es) | 2007-09-20 |
PL1987817T3 (pl) | 2010-01-29 |
US20090220608A1 (en) | 2009-09-03 |
KR101401273B1 (ko) | 2014-05-29 |
EP1987817A2 (en) | 2008-11-05 |
BRPI0707395A2 (pt) | 2011-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1987817T3 (da) | Farmaceutisk sammensætning til mikrosfærer til forebyggelse af diabetisk fodamputation | |
LTC2140867I2 (lt) | Farmacinė kompozicija | |
DK2054073T3 (da) | Farmaceutiske præparater til fremføring med langvarig frigivelse af peptider | |
DK2345410T3 (da) | Farmaceutisk sammensætning til modificeret frigivelse | |
DK2046264T3 (da) | Fremgangsmåder til fremstillingen af sammensætninger med film | |
DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
BRPI0715712A2 (pt) | Composição farmacêutica | |
BRPI0719393A2 (pt) | Composição farmacêutica | |
ES2527409T4 (es) | Formulaciones de inhibidores de DPP IV | |
DK2046767T3 (da) | Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser | |
DK2014652T3 (da) | Aktiveringsmiddel til peroxisom-proliferator-aktiveret receptor | |
DK2114386T3 (da) | Farmaceutisk sammensætning til behandling af diabeteskomplikationer | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
DK1984009T3 (da) | Farmaceutiske sammensætninger med forbedret stabilitet | |
DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
DK2063868T3 (da) | Farmaceutiske sammensætninger indeholdende rosuvastatin-calcium | |
DK2478907T3 (da) | Sammensætninger til behandling af kræft | |
DK2011486T3 (da) | Farmaceutiske sammensætninger af rifaximin | |
DK2180882T3 (da) | Farmaceutisk faststofsammensætning af matrix-type | |
BRPI0720234A2 (pt) | Composição farmacêutica | |
BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
DK2079577T3 (da) | Fremgangsmåde til fremstilling af fodtøj | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
NO20091266L (no) | Fremgangsmåter for administrering av langvarige hypoglykemiske midler | |
DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme |